Literature DB >> 9512103

Classification and epidemiology of scleroderma.

M D Mayes1.   

Abstract

Scleroderma is classified as two separate but related entities, a localized form and a systemic form. The classification scheme for morphea presented here is that of Peterson et al, which divides morphea into five categories: plaque, generalized, bullous, linear, and deep. Using this system, these authors estimated the incidence rate of localized scleroderma to be 27 new cases per million population per year. Overall survival was similar to that of the general population. There was a preponderance of female cases (approximately 3:1) for all forms of morphea except for linear scleroderma, which had an even sex distribution. Systemic scleroderma is divided into limited and diffuse disease based on the extent of skin involvement. Recent estimates have placed the incidence rate of systemic sclerosis in the United States at 19 new cases per million adults per year, with an overall prevalence of 240/million adults. The female-to-male ratio is approximately 5:1. The prevalence of scleroderma varies by geographic region and ethnic background and is higher in the United States than in Europe or Japan. Although systemic sclerosis survival has improved over the past two decades, with 5-year survival over 80%, long-term survival is significantly lower than expected, and morbidity is considerable.

Entities:  

Mesh:

Year:  1998        PMID: 9512103     DOI: 10.1016/s1085-5629(98)80058-8

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  10 in total

1.  Caught in a vice.

Authors:  Vipin Dulam; Suresh Keshavamurthy; Maruti Kumaran; Partha Hota; Carlos Gutierrez; Mohammed Abul Kashem; Yoshiya Toyoda
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-04-07

2.  Geographic disparity in systemic sclerosis mortality in the United States: 1999-2017.

Authors:  Alicia Rodriguez-Pla; Robert W Simms
Journal:  J Scleroderma Relat Disord       Date:  2019-08-26

3.  Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.

Authors:  Nand Lal Sharma; Vikram K Mahajan; Nitin Ranjan; Vikas Chander Sharma; Mudita Gupta
Journal:  Clin Rheumatol       Date:  2009-10-17       Impact factor: 2.980

4.  Systemic and cell type-specific gene expression patterns in scleroderma skin.

Authors:  Michael L Whitfield; Deborah R Finlay; John Isaac Murray; Olga G Troyanskaya; Jen-Tsan Chi; Alexander Pergamenschikov; Timothy H McCalmont; Patrick O Brown; David Botstein; M Kari Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

5.  Response of T-cell subpopulations to superantigen and recall antigen stimulation in systemic sclerosis.

Authors:  Sajad Ahmad Dar; Sambit Nath Bhattacharya; Shukla Das; Vishnampettai Ganapathysubramanian Ramachandran; Basu Dev Banerjee; Prateek Arora
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

6.  Interventions for morphea.

Authors:  Julia V de Albuquerque; Brenda Ng Andriolo; Monica Ra Vasconcellos; Vinicius T Civile; Anne Lyddiatt; Virginia Fm Trevisani
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

7.  Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin.

Authors:  Michael E Johnson; Jennifer M Franks; Guoshuai Cai; Bhaven K Mehta; Tammara A Wood; Kimberly Archambault; Patricia A Pioli; Robert W Simms; Nicole Orzechowski; Sarah Arron; Michael L Whitfield
Journal:  Arthritis Res Ther       Date:  2019-02-06       Impact factor: 5.606

8.  Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature.

Authors:  Daniel N Reed; David L Hall; James H Cottle; Katherine Frimenko; Christina K Horton; Farah Abu Sharkh; Rachel Beckett; Brandon Hernandez; Hannah Mabe; Shadee T Mansour; Sebastian A Rodriguez; Bradley Weprin; Leigh E Yarborough
Journal:  Clin Case Rep       Date:  2020-01-17

9.  Serum antioxidant status in patients with systemic sclerosis.

Authors:  Iffat Hassan; Peerzada Sajad; Sabiya Majid; Tehseen Hassan
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

10.  Molecular subsets in the gene expression signatures of scleroderma skin.

Authors:  Ausra Milano; Sarah A Pendergrass; Jennifer L Sargent; Lacy K George; Timothy H McCalmont; M Kari Connolly; Michael L Whitfield
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.